HLB Pharmaceutical Co (XKRX:047920) EBIT per Share : ₩51.97 (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is HLB Pharmaceutical Co EBIT per Share?

HLB Pharmaceutical Co's EBIT per Share for the three months ended in Dec. 2024 was ₩50.85. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩51.97.

During the past 3 years, the average EBIT per Share Growth Rate was 29.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for HLB Pharmaceutical Co's EBIT per Share or its related term are showing as below:

XKRX:047920' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -60.9 Med: 27.7 Max: 29.7
Current: 29.7

During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of HLB Pharmaceutical Co was 29.70% per year. The lowest was -60.90% per year. And the median was 27.70% per year.

XKRX:047920's 3-Year EBIT Growth Rate is ranked better than
75.61% of 824 companies
in the Drug Manufacturers industry
Industry Median: 8.3 vs XKRX:047920: 29.70

HLB Pharmaceutical Co's EBIT for the three months ended in Dec. 2024 was ₩1,500 Mil.

HLB Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for HLB Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Pharmaceutical Co EBIT per Share Chart

HLB Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-5,063.31

132.68

-217.00

-242.85

55.73

HLB Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial															170.38	-48.44	13.80	35.75	50.85

HLB Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

HLB Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1786.79	/	32.060
=	55.73

HLB Pharmaceutical Co's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1500.153	/	29.500
=	50.85

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩51.97

HLB Pharmaceutical Co (XKRX:047920) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

HLB Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of HLB Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

67, Euiui-ro, Songpa-gu, MK Tower 9th Floor, Seoul, KOR

Website

http://www.hlbpharma.co.kr

HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

HLB Pharmaceutical Co Headlines

No Headlines